Featured Articles

  1. Addressing Regulatory Challenges For Ophthalmic Combination Products 6/17/2026

    Classifying eye drops as combination products complicates approval. Learn how identifying the primary mode of action early and aligning dual quality frameworks prevents costly launch delays.

  2. What is Hot Melt Extrusion, And How Can It Benefit Your Drug Product? 6/17/2026

    Poor API solubility delays pipelines. Discover how hot-melt extrusion creates amorphous solid dispersions to break down crystal lattices and boost bioavailability via solvent-free manufacturing.

  3. Monoclonal Vs Polyclonal Antibody Production- Explained Step By Step 6/17/2026

    Selecting the optimal antibody framework is critical. Discover how monoclonal and polyclonal epitope specificity impacts manufacturing complexity, batch uniformity, and long-term therapeutic efficacy.

  4. What To Consider When Looking For A CDMO In Drug Substance Utilization 6/17/2026

    Optimize drug substance use during fill/finish. Learn how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.

  5. 3 Key Considerations When Choosing A Partner For Your Tech Transfer 6/15/2026

    One way to streamline tech transfer is to partner with a CMO demonstrating a proven track record across the entire drug development and manufacturing continuum.

  6. Data-Driven Approach Optimizes Robust, Scalable Lyophilization Process

    Selecting the right manufacturing partner with appropriate lyophilization expertise, experience, and analytical capabilities can speed drug development and expedite time to market for lyophilized drugs.

  7. Bilayer Tablet Manufacturing: An Overview

    Bilayer tablets offer a number of benefits for patient care; understanding the challenges that accompany their formulation is key to enabling their successful commercialization.

  8. CMO As Partners For ADC Process Development, Scale-Up, Optimization

    ADC programs can accelerate through clinical phases rapidly, making early preparation for commercial launch imperative. It's sensible to partner with a CMO with a strong biologics foundation.

  9. Minimizing API Supply Chain Risks

    Partnering with an API CMO can help you navigate challenges you may encounter, ensuring you are using the best quality practices and minimizing delays in getting those medicines to market.